Cells (Sep 2022)

Liquid–Liquid Phase Separation of Biomacromolecules and Its Roles in Metabolic Diseases

  • Zhihao Chen,
  • Ying Huai,
  • Wenjing Mao,
  • Xuehao Wang,
  • Kang Ru,
  • Airong Qian,
  • Hong Yang

DOI
https://doi.org/10.3390/cells11193023
Journal volume & issue
Vol. 11, no. 19
p. 3023

Abstract

Read online

Liquid–liquid phase separation (LLPS) compartmentalizes and concentrates biomacromolecules into liquid-like condensates, which underlies membraneless organelles (MLOs) formation in eukaryotic cells. With increasing evidence of the LLPS concept and methods, this phenomenon as a novel principle accounts for explaining the precise spatial and temporal regulation of cellular functions. Moreover, the phenomenon that LLPS tends to concentrate proteins is often accompanied by several abnormal signals for human diseases. It is reported that multiple metabolic diseases are strongly associated with the deposition of insoluble proteinaceous aggregating termed amyloids. At present, recent studies have observed the roles of LLPS in several metabolic diseases, including type 2 diabetes mellitus (T2DM), Alzheimer’s disease (AD), and metabolic bone diseases (MBDs). This review aims to expound on the current concept and methods of LLPS and summarize its vital roles in T2DM, AD, and MBDs, uncover novel mechanisms of these metabolic diseases, and thus provide powerful potential therapeutic strategies and targets for ameliorating these metabolic diseases.

Keywords